High-level expression of human cytochrome P450 3A4 by co-expression with human molecular chaperone HDJ-1 (Hsp40)

Archives of Pharmacal Research

Volumn 27, Issue 3, 2004, Pages 319-323

  Ahn, Taeho ^a   Yun, Chul Ho ^a  

^a Chonnam National University   (South Korea)

Author keywords

Chaperone; Co expresion; CYP3A4; HDJ 1

Indexed keywords

CHAPERONE; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; DNAJB1 PROTEIN, HUMAN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 40;

ARTICLE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PHYSIOLOGY;

CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEAT-SHOCK PROTEINS; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES;

EID: 7044231916     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980067     Document Type: Article

References (18)

1. Arlotto, M. P., Trant, J. M., and Estabrook, R. W., Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. Methods Enzymol., 206, 454-462 (1991).
2. Bao, Y. P., Cook, L. J., ODonovan, D., Uyama, E., and Rubinsztein, D. C., Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. J. Biol. Chem., 277, 12263-12269 (2002).
3. Distlerath, L. M., Reilly, P. E., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P., Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem., 260, 9057-9067 (1985).
4. Freeman, B. C. and Morimoto, R. I., The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J., 15, 2969-2979 (1996).
5. Gillam, E. M., Baba, T., Kim, B. R., Ohmori, S., and Guengerich, F. P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys., 305, 123-131 (1993).
6. Guengerich, F. P. and Parikh, A., Expression of drug-metabolizing enzymes. Curr. Opin. Biotechnol., 8, 623-628 (1997).
7. nd ed. Plenum Press, New York, pp.473-535 (1995).
8. Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F., Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch. Biochem. Biophys., 350, 324-332 (1998).
9. Inoue, E., Takahashi, Y., Imai, Y., and Kamataki, T., Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450. Biochem. Biophys. Res. Commun., 269, 623-627 (2000).
10. Iwata, H., Fujita, K-I., Kushida, H., Suzuki, A., Konno, Y., Nakamura, K., Fujino, A., and Kamataki, T., High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem. Pharmacol., 55, 1315-1325 (1998).
11. Nagata, H., Hansen, W. J., Freeman, B., and Welch, W. J., Mammalian cytosolic DnaJ homologues affect the hsp70 chaperone-substrate reaction cycle, but do not interact directly with nascent or newly synthesized proteins. Biochemistry, 37, 6924-6938 (1998).
12. Omura, T. and Sato, R., The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239, 2370-2378 (1964).
13. Parikh, A. and Guengerich, F. P., Expression, purification, and characterization of a catalytically active human cytochrome P450 3A4: Rat NADPH-cytochrome P450 fusion protein. Protein Expr. Purif., 9, 346-354 (1997).
14. Pritchard, M. P., Ossentian, R., Li, D. N., Henderson, C. J., Burchell, B., Wolf, R., and Friedberg, T., A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: Expression of CYP3A4, CYP2A6, and CYP2E1. Arch. Biochem. Biophys., 345, 342-354 (1997).
15. Sandhu, P., Baba, T., and Guengerich, F. P., Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch. Biochem. Biophys., 306, 443-450 (1993).
16. Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J., and Roe, B. A., Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J. Mol. Biol., 143, 161-178 (1980).
17. Tang, W. and Stearns, R. A., Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions. Curr. Drug Metab., 2, 185-198 (2001)
18. Wrighton, S. A. and Stevens, J. C., The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxcol., 22, 1-21 (1992).